| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |